Healios K.K.
October 5, 2026 Notice Regarding Shipment and Revenue Recognition of Initial Order of Conditioned Media Products to JENECELL
Shipped and recorded revenue for initial order of conditioned media products to JENECELL equivalent to 144 million yen. Revenue will be recognized in Q4 of the fiscal year ending December 2026. Discussions continue with JENECELL for ongoing orders.
Key Figures
- Key Figure 1: 144 million yen equivalent (shipment and revenue recognized)
- Key Figure 2: Q4 of the fiscal year ending December 2026 (timing of revenue recognition)
- Key Figure 3: Unknown (shipment volumes and number of other partners are unknown)
AI要約
Transaction Overview
Healios K.K. has shipped the initial order of conditioned media products to JENECELL and completed revenue recognition. This marks the first commercial shipment and represents a first step toward revenue opportunities beyond the regenerative medicine pipeline. We will continue discussions with JENECELL regarding shipment volumes and timing to secure ongoing orders. Conditioned media is expected to be used across multiple fields as a material for pharmaceuticals and cosmetics, and we plan to continue building relationships with other potential partners.
Outlook and Strategy
We will aim for continuous orders by continuing to discuss shipment volumes and timing with JENECELL. We will promote market expansion for product lines based on conditioned media and pursue relationships and negotiations with multiple partners to generate revenue opportunities beyond the regenerative medicine pipeline.
Healios K.K.
Company overview · Stock price · Financial data · All IR
